AcuityAds’ CTO, Dr. Nathan Mekuz to Present at StableView TECH17
TORONTO and NEW YORK – October 20th, 2017 – AcuityAds Holdings Inc. (TSXV:AT) (“AcuityAds” or “Company”), a technology leader that provides targeted digital media solutions enabling advertisers to connect intelligently with audiences across video, mobile, social and online display campaigns, today announced that the Company’s Chief Technology Officer, Dr. Nathan Mekuz, will be presenting at the StableView Asset Management TECH17 Conference on Tuesday, October 26, 2017 in Toronto, Canada. Dr. Mekuz will be delivering a brief presentation on the topic of how organizations are powering business innovation with Artificial Intelligence (AI). The StableView TECH17 conference is being held at the Arcadian Loft, located at 401 Bay Street, Simpson Tower, 8th Floor with AcuityAds presenting at 9:15 am.
About StableView TECH17
StableView Asset Management hosts StableView Tech17. The 4th annual StableView TECH17 showcases the most innovative ideas, themes and challenges in Technology today. As the only buy-side curated tech conference in Canada, StableView TECH17 sits at the junction of the public and private investing tech ecosystem in Canada and brings together participants that typically stay in their individual silos: institutional investors, pensions, VCs, broker-dealers, advisors, HNW investors and family offices with private and public tech companies in Canada.
On October 26th, 2017, approximately 25 of Canada’s leading technology companies will be presenting to an expected audience of over 450+ professionals representing approximately $350B in AUM.
About Dr. Nathan Mekuz
Dr. Nathan Mekuz is the Chief Technology Officer (CTO) and Vice President of Ad Operations and a Co-founder of AcuityAds Inc. Dr. Mekuz has served as Chief Technology Officer since October 2009 and Vice President of Ad Operations since February 2015. Dr. Mekuz has been researching Artificial Intelligence (AI) since 1997 and his work has been published and cited in numerous professional publications, textbooks and patents. Dr. Mekuz has played a key role in developing the proprietary AI technology that powers AcuityAds’ programmatic marketing platform.
AcuityAds is a technology company that enables marketers to connect intelligently with their most meaningful audiences through digital media. A Self-Serve programmatic marketing platform, powered by machine learning, is at the core of our business. This is accompanied by strategic digital advertising solutions that cater to social, mobile and video-specific needs. AcuityAds empowers marketers by offering transparency on costs and brand safety, and real-time reporting and analytics, bringing accountability to programmatic advertising to deliver business results.
AcuityAds is headquartered in Toronto, Canada with sales offices in New York City, Boston, Chicago, Los Angeles, San Francisco, San Diego, Dallas, Vancouver, Calgary, Montreal and London, England. For more information, visit AcuityAds.com.
For further information, please contact:
Disclaimer in regards to Forward-looking Statements
Certain statements included herein constitute “forward-looking statements” within the meaning of applicable securities laws. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management at this time, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Investors are cautioned not to put undue reliance on forward-looking statements. Except as required by law, AcuityAds does not intend, and undertakes no obligation, to update any forward-looking statements to reflect, in particular, new information or future events.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.